Security key
189464100
- Security type / class
- Equity / COM
- Total 13F shares
- 53,369,776
- Total 13F value
- $958,514,173
- Share change
- -2,184,238
- Put/Call ratio
- 45%
- SEC-reported price per share
- $17.96
- Number of holders
- 157
- Value change
- -$149,964,792
- Number of buys
- 82
- Number of sells
- 99
Open additional details 1 more signal available
Report period
Q4 2018
Institutions
157
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of CLVSQ - CLOVIS ONCOLOGY INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
157
Shares
53,369,776
Rows available
157
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
188
Q4 2018 holders
157
Holder diff
-31
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 value | Q4 2018 value | Value change | Value Chg % |
|---|